Study finds β-synuclein as early blood-based biomarker of Alzheimer's in Down syndrome patients
Decades before the first symptoms of Alzheimer's disease appear, some changes associated with the disease may begin to leave a trace in the blood.
Read original article on The Medical News →Related news
-
Clinical trial tests AI-assisted medication device for older adults with memory loss
United Kingdom
-
A Swarm of Seven Meteor Showers Will Light Up the Night Skies All October Long
United Kingdom
-
Ocean, desert rainfall and a parasitic disease: Researchers connect patterns
United Kingdom
-
'Herd-Immunity-on-a-Chip' recreates viral transmission within a simulated population
United Kingdom
-
Early warning signs of chronic pelvic pain may appear in adolescence, study finds
United Kingdom
-
Sauna rituals and expansion plans feature strongly in early bathhouse survey findings
United States
-
Years of opioid use do not improve chronic back pain, study finds
United Kingdom
-
Improving early detection of cognitive impairment in primary care
United Kingdom